Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression

No abstract is available for this paper.

• Publication year

  2018

• Venue

  The Prostate

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pros.23446PMID 29094395
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gland

  2020cited by this paper
• Estrogen receptor β, a regulator of androgen receptor signaling in the mouse ventral prostate

  2017cited by this paper
• Androgen Receptor Function and Androgen Receptor–Targeted Therapies in Breast Cancer: A Review

  2017cited by this paper
• Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer

  2016cited by this paper
• Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy.

  2016influential reference
• The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer

  2016influential reference
• Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone

  2016cited by this paper
• A basal stem cell signature identifies aggressive prostate cancer phenotypes

  2015cited by this paper
• Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial

  2015cited by this paper
• Estrogen and estrogen receptor alpha promotes malignancy and osteoblastic tumorigenesis in prostate cancer

  2015cited by this paper
• Stem Cells as Hormone Targets That Lead to Increased Cancer Susceptibility.

  2015cited by this paper
• TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.

  2014cited by this paper
• The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer

  2014cited by this paper
• Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer.

  2014influential reference
• Insight into the mechanisms of action of estrogen receptor β in the breast, prostate, colon, and CNS.

  2013cited by this paper
• Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.

  2013cited by this paper
• Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.

  2013cited by this paper
• Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer

  2011influential reference
• Common gene rearrangements in prostate cancer.

  2011cited by this paper
• Experience with fulvestrant acetate in castration-resistant prostate cancer patients.

  2010cited by this paper
• Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.

  2010influential reference
• Estrogen receptor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion

  2010cited by this paper
• From pathogenesis to prevention of castration resistant prostate cancer

  2010cited by this paper
• The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.

  2009cited by this paper
• CHARACTERIZATION OF TMPRSS2-ETS GENE ABERRATIONS IN ANDROGEN INDEPENDENT METASTATIC PROSTATE CANCER

  2008cited by this paper
• Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.

  2008cited by this paper
• Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.

  2008cited by this paper
• Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling

  2008influential reference
• Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study.

  2008influential reference
• Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.

  2008cited by this paper
• Inflammation in prostate carcinogenesis

  2007cited by this paper
• Estrogen action on the prostate gland: a critical mix of endocrine and paracrine signaling.

  2007influential reference
• Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.

  2006cited by this paper
• Dietary intake of phytoestrogens, estrogen receptor‐beta polymorphisms and the risk of prostate cancer

  2006cited by this paper
• The role of estrogens in prostate carcinogenesis: a rationale for chemoprevention.

  2005cited by this paper
• Estrogens and anti‐estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates

  2004cited by this paper
• Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis.

  2004cited by this paper
• Differential expression of the estrogen receptor beta (ERβ) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma

  2003cited by this paper
• Opportunities for prevention of prostate cancer: genetics, chemoprevention, and dietary intervention.

  2002cited by this paper
• Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.

  2002cited by this paper
• Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.

  2002cited by this paper
• Progesterone receptor expression in human prostate cancer: Correlation with tumor progression

  2001cited by this paper
• Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.

  2001cited by this paper
• Morphogenesis of prostate cancer.

  2001cited by this paper
• Comparative Studies of the Estrogen Receptors β and α and the Androgen Receptor in Normal Human Prostate Glands, Dysplasia, and in Primary and Metastatic Carcinoma

  2001cited by this paper
• Estrogen receptor‐β: Implications for the prostate gland

  1999cited by this paper
• Estrogen receptor-beta: implications for the prostate gland.

  1999cited by this paper
• Estrogen receptor expression in prostate cancer and premalignant prostatic lesions.

  1999influential reference
• Cloning of a novel receptor expressed in rat prostate and ovary.

  1996cited by this paper
• Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model

  1996cited by this paper
• Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation.

  1995cited by this paper
• Cáncer

  1939cited by this paper

• Exploring the bioactive compounds and molecular mechanisms of onion (Allium cepa L.) peels against prostate cancer through molecular docking and network pharmacology

  2026cites this paper
• Research advances on the risk of prostate cancer from phthalates exposure: from epidemiological evidence to multidimensional prevention and control

  2026cites this paper
• Advances in the identification of novel cell signatures in benign prostatic hyperplasia and prostate cancer using single-cell RNA sequencing

  2026cites this paper
• Targeting the feminized nature of prostate cancer exploring estrogen-driven metabolic reprogramming and its therapeutic intervention: а narrative review

  2025cites this paper
• Advances in Prostate Cancer Treatment: Exploring Molecular Targets and New Strategies in Castration-Resistant Disease

  2025cites this paper
• Uncovering the Tumorigenic Blueprint of PFOS and PFOA Through Multi-Organ Transcriptomic Analysis of Biomarkers, Mechanisms, and Therapeutic Targets

  2025cites this paper
• Interconnected study of molecular pathways: miR-137 as a central element at the intersection of lipid metabolism and prostate carcinogenesis

  2025cites this paper
• Integrative genomic and bioinformatic prioritization of drug repurposing candidates for prostate cancer

  2025cites this paper
• Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions

  2025cites this paper
• Transcriptomic Profile of Perineural Invasion in Prostate Cancer Identifies Prognostic Gene Signatures

  2025cites this paper
• Drug interactions with perfluorooctanoic acid and perfluorooctane sulfonate in cytotoxic activity against prostate cancer - in vitro studies.

  2025cites this paper
• RNA-Seq Uncovers Association of Endocrine-Disrupting Chemicals with Hub Genes and Transcription Factors in Aggressive Prostate Cancer

  2025cites this paper
• Endocrine-disrupting chemicals as prostate carcinogens

  2025cites this paper
• Estrogen signaling in prostate cancer: Novel ways to reactivate ER-β in castration-resistant prostate cancer

  2025cites this paper
• Analysis of Phthalate Monoesters and Bisphenols in Human Prostate Cancer Tissue and Urine.

  2025cites this paper
• Stachydrine hydrochloride induces cell senescence and ferroptosis of castration-resistant prostate cancer

  2025cites this paper
• Computational and Biological Insights for Anti-Cancer Effects of Karanjin through AR/ER Modulation, ROS Generation and Cell Cycle Arrest in Prostate Cancer

  2025cites this paper
• Hacia una nueva clasificación de los métodos anticonceptivos para un mejor desarrollo sostenible. Un enfoque bioético global

  2025cites this paper
• An Estrogen Receptor β Agonist with AR Antagonist Activity from a Modern Asymmetric De Novo Steroid Synthesis.

  2025cites this paper
• MLDockKit: A Precision Drug Discovery Platform for Prostate Cancer

  2025cites this paper
• Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms

  2025influential citation
• Tracing the Evolution of Sex Hormones and Receptor‐Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease

  2025cites this paper
• Improving drug repositioning with negative data labeling using large language models

  2025cites this paper
• A case of stromal sarcoma of the prostate with the incidental detection of prostate adenocarcinoma

  2025cites this paper
• An update on selective estrogen receptor modulator: repurposing and formulations

  2025cites this paper
• Signaling crosstalk of Galectin-3, β-catenin, and estrogen receptor in androgen-independent prostate cancer DU-145 cells.

  2025cites this paper
• Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancer

  2025cites this paper
• Comparative Digital Estrogen Receptor Alpha (ERα) Expression Analysis in Benign and Malignant Prostate Tissue of Men and Dogs

  2025influential citation
• Estrogen receptor signaling and targets: Bones, breasts and brain (Review).

  2024cites this paper
• Estrogen receptor ER-α36: A diagnostic biomarker for endometrial cancer

  2024cites this paper
• Update on 18F-Fluoroestradiol.

  2024cites this paper
• Therapeutic prospects of sex hormone receptor signaling in hormone-responsive cancers.

  2024cites this paper
• Steroid hormones in fish, caution for present and future: A review

  2024cites this paper
• Lower PHI, [-2]proPSA/fPSA and testosterone/estradiol ratios in healthy black men: preliminary results and potential implications in prostate cancer clinical management.

  2024cites this paper
• Quercetin and taxifolin inhibits TMPRSS2 activity and its interaction with EGFR in paclitaxel‐resistant breast cancer cells: An in silico and in vitro study

  2024cites this paper
• The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens

  2024cites this paper
• Prostate cancers with distinct transcriptional programs in Black and White men

  2024cites this paper
• Prostate cancer in transgender women: A propensity score–matched analysis of disease severity and survival

  2024cites this paper
• La planificación familiar como solución al cambio climático. Dilemas bioéticos en el contexto del Desarrollo Sostenible

  2024cites this paper
• Characterization of an Estrogen Receptor α-Selective 18 F-Estradiol PET Tracer

  2024cites this paper
• The Role of Estrogen and Estrogen Receptors in Head and Neck Tumors

  2024cites this paper
• Androgen Receptor and Estrogen Receptor Variants in Prostate and Breast Cancers.

  2024cites this paper
• The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression

  2024influential citation
• Analysis of the Gene Networks and Pathways Correlated with Tissue Differentiation in Prostate Cancer

  2024cites this paper
• After effects of Pharmaceuticals and Personal Care Products (PPCPs) on the biosphere and their counteractive ways

  2024cites this paper
• Positive correlation between the nuclear expression of GPER and pGLI3 in prostate cancer tissues from patients with different Gleason scores

  2024cites this paper
• New mode of action of curcumin on prostate cancer cells: Modulation of endoplasmic reticulum‐associated degradation mechanism and estrogenic signaling

  2024cites this paper
• Neonatal exposure to aluminum chloride predisposes adult and senile gerbils to the prostatic hyperplasia

  2023cites this paper
• Incidence of Prostate Cancer in Transgender Women Undergoing Androgen Deprivation Therapy: A Review

  2023cites this paper
• The effect of Iranian licorice root extract on prostate volume and clinical signs of disease in patients with benign prostatic hyperplasia

  2023cites this paper
• Associations of Phthalates with Prostate Cancer among the US Population.

  2023cites this paper
• The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects

  2023cites this paper
• Glyceollins from soybean: Their pharmacological effects and biosynthetic pathways

  2023cites this paper
• Early-life origin of prostate cancer through deregulation of miR-206 networks in maternally malnourished offspring rats

  2023cites this paper
• Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function

  2023influential citation
• Novel hybrid motifs of 4-nitroimidazole-piperazinyl tagged 1,2,3-triazoles: Synthesis, crystal structure, anticancer evaluations, and molecular docking study

  2023cites this paper
• Trends in estrogen and progesterone receptors in prostate cancer: a bibliometric analysis

  2023cites this paper
• The Transcriptomic Profiles of ESR1 and MMP3 Stratify the Risk of Biochemical Recurrence in Primary Prostate Cancer beyond Clinical Features

  2023cites this paper
• Prognostic value of estrogen receptors in patients who underwent prostatectomy for non‑metastatic prostate cancer.

  2023cites this paper
• The Lack of Standardization and Pharmacological Effect Limits the Potential Clinical Usefulness of Phytosterols in Benign Prostatic Hyperplasia

  2023cites this paper
• Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants

  2023cites this paper
• MATCHING BRCA AND PROSTATE CANCER IN A PUBLIC HEALTH SYSTEM: REPORT OF THE ITALIAN SOCIETY FOR URO-ONCOLOGY (SIUrO) CONSENSUS PROJECT.

  2023cites this paper
• Molecular regulation of prostate cancer by Galectin-3 and estrogen receptor

  2023cites this paper
• To block or not to block—hormonal signaling in the treatment of cancers

  2023cites this paper
• Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer

  2023cites this paper
• Molecular Mechanisms of Coffee on Prostate Cancer Prevention

  2022cites this paper
• The endocrine and epigenetic impact of persistent cow milk consumption on prostate carcinogenesis

  2022cites this paper
• Distribution and Effects of Estrogen Receptors in Prostate Cancer: Associated Molecular Mechanisms

  2022cites this paper
• The HeyL-Aromatase Axis Promotes Cancer Stem Cell Properties by Endogenous Estrogen-Induced Autophagy in Castration-Resistant Prostate Cancer

  2022cites this paper
• Exploration of Extracellular Vesicle miRNAs, Targeted mRNAs and Pathways in Prostate Cancer: Relation to Disease Status and Progression

  2022cites this paper
• Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers

  2022cites this paper
• Urolithins: The Colon Microbiota Metabolites as Endocrine Modulators: Prospects and Perspectives

  2022cites this paper
• Antibody Validation for Estrogen Receptor Beta.

  2022cites this paper
• Signal Crosstalk and the Role of Estrogen Receptor beta (ERβ) in Prostate Cancer

  2022cites this paper
• Tadalafil and Steroid Hormones Interactions in Adipose, Bone and Prostate Tissues: Focus on Translational Perspectives

  2022cites this paper
• Impact of chronic exposure of rats to bisphenol A from perinatal period to adulthood on intraprostatic levels of 5α-reductase isozymes, aromatase, and genes implicated in prostate cancer development.

  2022cites this paper
• Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment

  2022cites this paper
• Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer

  2022cites this paper
• Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions

  2022cites this paper
• Estrogen Receptor Expression is Modulated in Human and Mouse Prostate Epithelial Cells during Cancer Progression.

  2022cites this paper
• Network Pharmacology with Experimental Investigation of the Mechanisms of Rhizoma Polygonati against Prostate Cancer with Additional Herbzymatic Activity

  2022cites this paper
• Estrogens, Cancer and Immunity

  2022cites this paper
• High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells

  2022cites this paper
• Androgen receptor signaling and spatial chromatin organization in castration-resistant prostate cancer

  2022cites this paper
• Role of estrogen receptors in health and disease

  2022cites this paper
• DIAGNOSTIC POTENTIAL VALUE OF CIRCULATING PCA3 mRNA IN PLASMA AND URINE OF PROSTATE CANCER PATIENTS

  2022cites this paper
• Molecular Mechanism of Tanshinone against Prostate Cancer

  2022cites this paper
• Endometrium kanserinde hormon reseptölerinin prognostik önemi

  2022cites this paper
• Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches

  2022cites this paper
• Exploring the Mechanism of Astragalus membranaceus in the Treatment of Prostate Cancer Based on Network Pharmacology and Molecular Docking

  2022cites this paper
• Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel

  2022cites this paper
• Prostate cancer in transgender women: considerations for screening, diagnosis and management

  2022influential citation
• The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer

  2022cites this paper
• miR-18a-5p Is Involved in the Developmental Origin of Prostate Cancer in Maternally Malnourished Offspring Rats: A DOHaD Approach

  2022cites this paper
• Prostate Cancer Disparities and Management in Southern Africa: Insights into Practices, Norms and Values

  2022cites this paper
• The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor.

  2021cites this paper
• Identi cation of the active substance and mechanisms of CFF-1 for treatment of prostate cancer based on network pharmacology, virtual screening, and molecular dynamics simulation

  2021cites this paper
• Hibiscus sabdariffa anthocyanins are potential modulators of estrogen receptor alpha activity with favourable toxicology: a computational analysis using molecular docking, ADME/Tox prediction, 2D/3D QSAR and molecular dynamics simulation

  2021cites this paper
• Transcriptomic landscape of male and female reproductive cancers: Similar pathways and molecular signatures predicting response to endocrine therapy.

  2021cites this paper
• Transcriptomic analysis of castration, chemo-resistant and metastatic prostate cancer elucidates complex genetic crosstalk leading to disease progression

  2021cites this paper